Borderline Personality Disorder and Emotion Dysregulation

《Borderline Personality Disorder and Emotion Dysregulation》是 2014 年创刊的开放获取期刊，由 BioMed Central 出版，同时是欧洲人格障碍研究学会的会刊。

刊物聚焦边缘型人格障碍与情绪失调的心理、社会与神经生物学层面，也讨论流行病学、现象学、治疗与动物模型。

2025 年期刊影响因子为 3.2，五年影响因子为 4.9，在精神病学 293 种期刊中排第 103 位。

Scope

• Borderline personality disorder is the organising subject, approached as a severe and still under-treated psychiatric condition.边缘型人格障碍是刊物的组织核心，被当作一种严重且治疗仍不充分的精神疾病。
• Emotion regulation and dysregulation are studied both within BPD and as transdiagnostic processes.情绪调节与失调既在边缘型人格障碍内部研究，也作为跨诊断过程加以考察。
• Neurobiological papers use imaging, psychophysiology and neuroendocrinology to map affective instability.神经生物学论文借助影像、心理生理与神经内分泌手段描绘情感不稳。
• Genetic and epigenetic studies examine heritability, gene-environment interaction and stress-related methylation.遗传与表观遗传研究考察遗传度、基因环境交互以及应激相关的甲基化。
• Animal models are used to probe the mechanisms of impulsive aggression and social rejection.动物模型用于探究冲动性攻击与社会排斥的机制。
• Epidemiology contributions report prevalence, course and service use in defined populations.流行病学稿件报告特定人群中的患病率、病程与服务使用。
• Phenomenology and diagnostic assessment papers address classification, interview instruments and self-report scales.现象学与诊断评估论文处理分类、访谈工具与自评量表。
• Psychotherapy trials evaluate dialectical behaviour therapy, mentalisation-based treatment and schema-focused approaches.心理治疗试验评估辩证行为治疗、心智化治疗与图式聚焦疗法。
• Pharmacological studies report on mood stabilisers, antipsychotics and opioid antagonists.药物研究报告心境稳定剂、抗精神病药与阿片受体拮抗剂的效果。
• Co-occurring conditions receive close attention, including post-traumatic stress disorder, ADHD and depression.共病状况受到密切关注，包括创伤后应激障碍、注意缺陷多动障碍与抑郁。
• Eating disorders, conduct disorders, substance misuse and social phobia are studied as frequent companions of BPD.进食障碍、品行障碍、物质滥用与社交恐惧被作为边缘型人格障碍的常见伴随问题研究。
• Self-harm and suicidal behaviour are examined through clinical cohorts and emergency settings.自伤与自杀行为通过临床队列与急诊环境加以考察。
• Childhood maltreatment and attachment disruption are treated as developmental antecedents rather than side issues.童年虐待与依恋中断被当作发展性前因，而不是旁枝问题。
• Social interaction, rejection sensitivity and disturbed self-concept are core psychological topics.社会互动、拒绝敏感与自我概念紊乱是核心心理学题目。
• Dimensional models of personality pathology are tested against categorical diagnosis.人格病理的维度模型与分类诊断相互检验。
• Health services and implementation research examines access, dropout and staff training.卫生服务与实施研究考察可及性、脱漏与人员培训。
• Stigma and public attitudes toward people with personality disorder appear in occasional studies.针对人格障碍患者的污名与公众态度也见于部分研究。
• Ecological momentary assessment and digital monitoring are used to capture affect in daily life.生态瞬时评估与数字监测被用于捕捉日常生活中的情绪变化。

• Personality disorder in adolescence is studied with attention to developmental trajectories and early intervention.青少年期人格障碍研究关注发展轨迹与早期干预。
• Neuroimaging work examines amygdala, prefrontal and insular circuits during social exclusion and pain.神经影像工作考察社会排斥与疼痛条件下的杏仁核、前额叶与岛叶回路。
• Treatment dropout, alliance and therapist training are examined as implementation questions.治疗脱漏、治疗联盟与治疗师培训作为实施问题加以考察。

History

• The journal was launched in 2014 by BioMed Central as an open-access title.刊物于 2014 年由 BioMed Central 以开放获取形式创办。
• It serves as the official journal of the European Society for the Study of Personality Disorders.刊物是欧洲人格障碍研究学会的官方会刊。
• Early issues carried reviews on emotion processing, psychotherapy for suicidal patients and impulsivity.早期各期刊载情绪加工、自杀患者心理治疗与冲动性方面的综述。
• Articles appear continuously and are collected into an annual volume.论文连续上线，按年度汇集为一卷。
• The title is indexed in MEDLINE and PubMed, Science Citation Index Expanded, Scopus and the Directory of Open Access Journals.刊物被 MEDLINE 与 PubMed、科学引文索引扩展版、Scopus 以及开放获取期刊目录收录。
• Impact factor history runs 3.297 in 2021, 4.463 in 2022, 4.0 in 2023, 2.7 in 2024 and 3.2 in 2025.影响因子历年数值为 2021 年 3.297、2022 年 4.463、2023 年 4.0、2024 年 2.7 与 2025 年 3.2。
• The 2025 five-year impact factor is 4.9, placing the journal in the first quartile on that measure.2025 年五年影响因子为 4.9，按该指标刊物处于第一四分位。
• In 2025 it ranks 103 of 293 in Psychiatry, in the second quartile at the 65th percentile.2025 年刊物在精神病学 293 种期刊中列第 103 位，处于第二四分位，百分位为 65。
• The 2025 window recorded 1318 citations to 53 articles, with 54 citable items.2025 年统计窗口记录 1318 次引用，施引对象为 53 篇论文，可被引条目 54 项。
• All recent articles were published gold open access.近年论文全部以金色开放获取方式发表。
• The median time from submission to first decision is twelve days.从投稿到首次决定的中位时间为十二天。
• The journal recorded 692400 downloads in 2025.2025 年刊物下载量为 69.24 万次。
• With the BMC portfolio it moved to Springer Nature Link, where its archive now sits.随着 BMC 期刊群迁转，刊物移至施普林格·自然链接平台，过刊存放于该处。
• Publication is funded by an article processing charge, consistent with the BMC open-access model.出版经费来自文章处理费，与 BMC 的开放获取模式一致。
• Members of the society contribute to special collections and to the journal's annual scientific programme.学会成员参与专题合集以及刊物的年度学术议程。

• The journal has published collections on stigma, on early detection and on co-occurring trauma.刊物曾推出污名、早期识别与共病创伤方面的合集。
• Its annual volume gathers articles that first appear online without an issue assignment.年度卷汇集先在线发表、尚未编入期次的论文。

Editors

• Annegret Krause-Utz, at Leiden University, is one of the three editors-in-chief.莱顿大学的 Annegret Krause-Utz 是三位主编之一。
• John M. Oldham, distinguished emeritus professor at Baylor College of Medicine, shares the editorship.贝勒医学院荣休教授 John M. Oldham 共同担任主编。
• Christian Schmahl, medical director at the Central Institute of Mental Health in Mannheim, is the third editor-in-chief.曼海姆中央精神卫生研究所医疗主任 Christian Schmahl 是第三位主编。
• Alexandra Philipsen, at the University Hospital Bonn, is a section editor.波恩大学医院的 Alexandra Philipsen 担任分栏编辑。
• Kathleen Thomaes, at Sinai Centrum in Amstelveen, covers trauma-related and dissociative presentations.阿姆斯特尔芬西奈中心的 Kathleen Thomaes 负责创伤相关与解离表现。
• Salome Vanwoerden, at the University of Pittsburgh, handles developmental and assessment research.匹兹堡大学的 Salome Vanwoerden 负责发展与评估研究。
• Anthony Bateman, at University College London, represents mentalisation-based treatment.伦敦大学学院的 Anthony Bateman 代表心智化治疗方向。
• Andrew Chanen, at the University of Melbourne, works on early intervention for personality disorder.墨尔本大学的 Andrew Chanen 研究人格障碍的早期干预。
• Alexander L. Chapman, at Simon Fraser University, studies emotion regulation and self-harm.西蒙弗雷泽大学的 Alexander L. Chapman 研究情绪调节与自伤。
• Sabine Herpertz, at Heidelberg University, brings affective neuroscience and clinical psychiatry.海德堡大学的 Sabine Herpertz 带来情感神经科学与临床精神病学视角。
• Michael Kaess, at the University of Bern, covers adolescence and non-suicidal self-injury.伯尔尼大学的 Michael Kaess 负责青少年期与非自杀性自伤。
• Shelley McMain, at the Centre for Addiction and Mental Health in Toronto, represents psychotherapy trials.多伦多成瘾与精神卫生中心的 Shelley McMain 代表心理治疗试验方向。
• Lars Mehlum, at the University of Oslo, works on suicidal behaviour and dialectical behaviour therapy.奥斯陆大学的 Lars Mehlum 研究自杀行为与辩证行为治疗。
• Mary C. Zanarini, at Harvard Medical School, contributes long-term follow-up research on BPD.哈佛医学院的 Mary C. Zanarini 贡献边缘型人格障碍的长期随访研究。
• Martin Bohus, of Heidelberg University, is editor-in-chief emeritus.海德堡大学的 Martin Bohus 为荣休主编。
• Ulrich Ebner-Priemer, at the Karlsruhe Institute of Technology, advises on ambulatory assessment methods.卡尔斯鲁厄理工学院的 Ulrich Ebner-Priemer 就动态评估方法提供咨询。
• Manuscripts are submitted through the Springer Nature portal and assigned to an editor by topic.稿件经施普林格·自然投稿门户提交，并按主题分派给编辑。
• Section editors screen submissions and recommend reviewers from outside their own institutions.分栏编辑初筛稿件，并推荐本机构以外的审稿人。